amcipatricin

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug Nameamcipatricin
Drug Alias NameSPK-843IDSPA-S-843SPK-843SPA-A-753 (Diaspartate salt)SPA-S-752 (free base) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsCryptococcosisAspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSocieta Prodotti Antibiotici
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProaparts Srl
Active IndicationsN/A
Inactive IndicationsCryptococcosisAspergillosis

Other Information

ATC CodeN/A
Related LinksN/A